These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 2591267

  • 1. [Serum complement composition of myasthenia gravis].
    Hao ZS.
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Jun; 22(3):141-3, 190. PubMed ID: 2591267
    [Abstract] [Full Text] [Related]

  • 2. Complement levels in cigarette smokers: elevation of serum concentrations of C5, C9, and C1-inhibitor.
    Wyatt RJ, Bridges RB, Halatek DG.
    J Clin Lab Immunol; 1981 Sep; 6(2):131-5. PubMed ID: 7288869
    [Abstract] [Full Text] [Related]

  • 3. [Complement components, whole complement activity, and circulating immune complexes in neoplastic diseases].
    Takada K, Morishita M, Sugiura T, Suzuki M, Torii Y, Ichimura K, Hashigami H, Toshikawa K, Ina Y, Yamamoto M, Oyama A, Urata A.
    Gan No Rinsho; 1983 Apr; 29(4):A-19, 293-6. PubMed ID: 6602233
    [Abstract] [Full Text] [Related]

  • 4. The effect of aging on complement activity (CH50) and complement protein levels.
    Nagaki K, Hiramatsu S, Inai S, Sasaki A.
    J Clin Lab Immunol; 1980 Jan; 3(1):45-50. PubMed ID: 7381926
    [Abstract] [Full Text] [Related]

  • 5. Complement levels of C4, C3C, factor B, and C1 inactivator in peripheral and retroplacental blood of parturient women with EPH gestosis.
    Zdanowicz A, Jabłońska E, Pietruska Z, Bielecki M.
    Ann Med Univ Bialyst Pol; 1993 Jan; 38(1):60-7. PubMed ID: 7922487
    [Abstract] [Full Text] [Related]

  • 6. Predictive value of serum anti-C1q antibody levels in experimental autoimmune myasthenia gravis.
    Tüzün E, Saini SS, Ghosh S, Rowin J, Meriggioli MN, Christadoss P.
    Neuromuscul Disord; 2006 Feb; 16(2):137-43. PubMed ID: 16427283
    [Abstract] [Full Text] [Related]

  • 7. [Evaluation of C3c, C4 and C1-esterase inhibitor (C1-INH) during unstable angina].
    Danese C, Marcianò F, Ciarla MV, Colotto M, Angrisani L, Ferranti E, Borgia MC.
    Minerva Cardioangiol; 2002 Dec; 50(6):667-72. PubMed ID: 12473987
    [Abstract] [Full Text] [Related]

  • 8. Beneficial effects of C1 esterase inhibitor in ST-elevation myocardial infarction in patients who underwent surgical reperfusion: a randomised double-blind study.
    Fattouch K, Bianco G, Speziale G, Sampognaro R, Lavalle C, Guccione F, Dioguardi P, Ruvolo G.
    Eur J Cardiothorac Surg; 2007 Aug; 32(2):326-32. PubMed ID: 17576071
    [Abstract] [Full Text] [Related]

  • 9. [Activity of total complement and concentration of its components C1q, C3, C4 and C1-inactivator in cancer].
    Matoses Cuquerella S, O'Connor Miquel C, Lluch Hernández AM, García-Conde Bru J.
    Med Clin (Barc); 1988 Dec 10; 91(20):769-74. PubMed ID: 3266280
    [No Abstract] [Full Text] [Related]

  • 10. Serum concentrations of immunoglobulins and complement components in patients with recurrence after resection of gastric carcinoma.
    Janssen CW, Tønder O, Matre R.
    Cancer Detect Prev; 1987 Dec 10; 10(3-4):303-9. PubMed ID: 3568028
    [Abstract] [Full Text] [Related]

  • 11. Administration of C1-esterase inhibitor during emergency coronary artery bypass surgery in acute ST-elevation myocardial infarction.
    Thielmann M, Marggraf G, Neuhäuser M, Forkel J, Herold U, Kamler M, Massoudy P, Jakob H.
    Eur J Cardiothorac Surg; 2006 Aug 10; 30(2):285-93. PubMed ID: 16829095
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of acute passive transfer experimental autoimmune myasthenia gravis with Fab antibody to complement C6.
    Biesecker G, Gomez CM.
    J Immunol; 1989 Apr 15; 142(8):2654-9. PubMed ID: 2703710
    [Abstract] [Full Text] [Related]

  • 13. A shared effect of abscesses and nonviable tissue influencing the development of sepsis and acute respiratory distress syndrome.
    Heideman M.
    Acta Chir Scand Suppl; 1982 Apr 15; 508():295-302. PubMed ID: 6952692
    [Abstract] [Full Text] [Related]

  • 14. C3 nephritic factor and C4 nephritic factor in the serum of two patients with hypocomplementaemic membranoproliferative glomerulonephritis.
    Tanuma Y, Ohi H, Watanabe S, Seki M, Hatano M.
    Clin Exp Immunol; 1989 Apr 15; 76(1):82-5. PubMed ID: 2736802
    [Abstract] [Full Text] [Related]

  • 15. C1-INH and C3/C4 levels do not correlate with long-term danazole dosage and HAE-1 attack-free interval.
    Schneider LA, Maetzke J, Staib G, Scharffetter-Kochanek K.
    Allergy; 2005 Sep 15; 60(9):1214-5. PubMed ID: 16076313
    [No Abstract] [Full Text] [Related]

  • 16. Myasthenia gravis: demonstration of membrane attack complex in muscle end-plates.
    Fazekas A, Komoly S, Bózsik B, Szobor A.
    Clin Neuropathol; 1986 Sep 15; 5(2):78-83. PubMed ID: 3519034
    [Abstract] [Full Text] [Related]

  • 17. Involvement of complement in psoriasis and atopic dermatitis--measurement of C3a and C5a, C3, C4 and C1 inactivator.
    Kapp A, Wokalek H, Schöpf E.
    Arch Dermatol Res; 1985 Sep 15; 277(5):359-61. PubMed ID: 3875319
    [Abstract] [Full Text] [Related]

  • 18. The acquired C1-INH deficiencies with autoantibodies (AAE type II).
    Alsenz J, Loos M.
    Behring Inst Mitt; 1989 Jul 15; (84):165-72. PubMed ID: 2679532
    [Abstract] [Full Text] [Related]

  • 19. Involvement of complement in atopic dermatitis.
    Kapp A, Schöpf E.
    Acta Derm Venereol Suppl (Stockh); 1985 Jul 15; 114():152-4. PubMed ID: 3923750
    [Abstract] [Full Text] [Related]

  • 20. [A case of hereditary angioneurotic edema provoked by functional insufficiency of C1-inactivator].
    Didkovskiĭ NA, Paskhina TS, Rabinovich SE, Nartikova VF, Dvoretskiĭ LI.
    Ter Arkh; 1989 Jul 15; 61(6):116-9. PubMed ID: 2799695
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.